Outlook Wealth Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

Outlook Wealth Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $9,608 - $17,525	-154 Reduced 1.92%	7,869 $895,000
Q3 2022 Oct 25, 2022	BUY	$58.92 - $84.67 $1,590 - $2,286	27 Added 0.34%	8,023 $496,000
Q2 2022 Jul 28, 2022	BUY	$79.4 - $116.36 $15,006 - $21,992	189 Added 2.42%	7,996 $637,000
Q1 2022 Jul 28, 2022	BUY	$86.42 - $109.81 $25,321 - $32,174	293 Added 3.9%	7,807 $822,000
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $30,160 - $38,323	-349 Reduced 4.44%	7,514 $791,000

Q4 2021 Jan 21, 2022	BUY	$98.56 - $119.91 $22,471 - $27,339	228 Added 2.99%	7,863 $847,000
Q3 2021 Oct 22, 2021	BUY	$91.91 - $110.37 $11,580 - $13,906	126 Added 1.68%	7,635 $836,000
Q2 2021 Jul 21, 2021	BUY	$86.24 - $95.92 $344 - $383	4 Added 0.05%	7,509 $703,000
Q1 2021 May 04, 2021	SELL	$71.83 - $95.48 $44,031 - $58,529	-613 Reduced 7.55%	7,505 $691,000
Q4 2020 Feb 04, 2021	BUY	$67.0 - $84.39 $8,576 - $10,801	128 Added 1.6%	8,118 $594,000
Q3 2020 Nov 10, 2020	BUY	$55.23 - $79.93 $441,287 - $638,640	7,990 New	7,990 $621,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Outlook Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Outlook Wealth Advisors, LLC with notifications on news.